Search - tctmd.com

Displaying 21 - 40 of 563

Sort: Relevancy | Date

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

CMS Proposes Increased Reimbursement for Cardiac CT Angiography

Michael O'Riordan

August 16, 2024

News Daily News

CMR Could Change Diagnosis, Management of Suspected NSTEMI: OxAMI

Yael L. Maxwell

July 18, 2024

News Daily News

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Michael O'Riordan

July 01, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

HF Severity, Outcomes Tied to Markers of Neurodegeneration

Todd Neale

June 04, 2024

News Daily News

With ANOCA, Better to Test Coronary Function in Multiple Vessels

Caitlin E. Cox

May 29, 2024

News Daily News

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Michael O'Riordan

March 26, 2024

News Daily News

Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA

Michael O'Riordan

March 14, 2024

News Daily News

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Todd Neale

March 04, 2024

News Daily News

DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients

Michael O'Riordan

March 04, 2024

News Daily News

High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

Michael O'Riordan

February 29, 2024

News Daily News

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Michael O'Riordan

February 08, 2024

News Daily News

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Michael O'Riordan

January 30, 2024

News Daily News

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Michael O'Riordan

January 09, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

News Daily News

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Michael O'Riordan

December 27, 2023

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Daily News

Millions of Lives Lost to CVD Each Year: ‘Almanac’ Updates Global Burden

Caitlin E. Cox

December 12, 2023

Advertisement

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Scientific Statement Reviews Current Antithrombotic Options in PAD

CMS Proposes Increased Reimbursement for Cardiac CT Angiography

CMR Could Change Diagnosis, Management of Suspected NSTEMI: OxAMI

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

HF Severity, Outcomes Tied to Markers of Neurodegeneration

With ANOCA, Better to Test Coronary Function in Multiple Vessels

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients

High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Top Coronary Artery Disease News of 2023

Millions of Lives Lost to CVD Each Year: ‘Almanac’ Updates Global Burden

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content